MeSH term
Frequency | Condition_Probility | Base Sequence | 6 | 0.0 |
Child, Preschool | 6 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Germ-Line Mutation | 2 | 0.0 |
Humans | 32 | 0.0 |
Loss of Heterozygosity | 9 | 1.0 |
Male | 19 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 2 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Signal Transduction/genetics | 2 | 0.0 |
Animals | 5 | 0.0 |
Carcinoma, Basal Cell/genetics | 2 | 16.0 |
DNA Primers | 2 | 0.0 |
Mice | 4 | 0.0 |
*Mutation | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Membrane Proteins/*genetics | 12 | 1.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Tumor Markers, Biological | 2 | 0.0 |
Bladder Neoplasms/*genetics | 3 | 3.0 |
Chromosome Aberrations | 2 | 0.0 |
*Genes, Tumor Suppressor | 3 | 0.0 |
Middle Aged | 12 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Adult | 11 | 0.0 |
Cytoskeletal Proteins/*genetics | 2 | 1.0 |
Female | 18 | 0.0 |
Pedigree | 3 | 0.0 |
*Trans-Activators | 5 | 0.0 |
Aged | 9 | 0.0 |
Aged, 80 and over | 6 | 0.0 |
Carcinoma, Squamous Cell/*genetics | 2 | 1.0 |
*Point Mutation | 2 | 0.0 |
Skin Neoplasms/*genetics | 3 | 2.0 |
Crosses, Genetic | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Genetic Markers | 3 | 0.0 |
Genotype | 4 | 0.0 |
Mutation | 4 | 0.0 |
*Receptors, G-Protein-Coupled | 3 | 1.0 |
Polymorphism, Genetic | 6 | 0.0 |
Adolescent | 9 | 0.0 |
*Chromosomes, Human, Pair 9 | 2 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Alleles | 2 | 0.0 |
DNA Mutational Analysis | 6 | 0.0 |
DNA Primers/chemistry | 3 | 0.0 |
DNA, Neoplasm/genetics | 4 | 0.0 |
Genes, Tumor Suppressor | 4 | 0.0 |
Polymorphism, Single-Stranded Conformational | 8 | 0.0 |
Child | 8 | 0.0 |
Gene Deletion | 2 | 0.0 |
Infant | 5 | 0.0 |
Phenotype | 3 | 0.0 |
Gene Frequency | 2 | 0.0 |
Medulloblastoma/*genetics | 2 | 9.0 |
Point Mutation | 2 | 0.0 |
Basal Cell Nevus Syndrome/*genetics/metabolism | 2 | 100.0 |
Chromosomes, Human, Pair 9/genetics | 2 | 1.0 |
Skin Neoplasms/*genetics/metabolism | 5 | 25.0 |
Basal Cell Nevus Syndrome/*genetics | 2 | 25.0 |
Carcinoma, Basal Cell/genetics/metabolism | 2 | 66.0 |
*Drosophila Proteins | 4 | 0.0 |
Membrane Proteins/*genetics/metabolism | 2 | 1.0 |
Neoplasm Proteins/*genetics/metabolism | 2 | 1.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Chromosomes, Human, Pair 9 | 3 | 1.0 |
Comparative Study | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Brain Neoplasms/*genetics/metabolism | 2 | 7.0 |
Carcinoma, Basal Cell/*genetics/metabolism | 2 | 40.0 |
Neuroectodermal Tumors, Primitive/*genetics/metabolism | 2 | 40.0 |
In Situ Hybridization | 2 | 0.0 |
Exons | 2 | 0.0 |
